Copyright
©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 94914
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.94914
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.94914
Figure 1 Kaplan-Meier survival curves.
A: Kaplan-Meier curve of statin use vs a composite endpoint of hepatocellular carcinoma (HCC)-recurrence and all-cause mortality (P = 0.9); B: Kaplan-Meier curve of statin use vs HCC-recurrence (P = 0.5); C: Kaplan-Meier curve of statin use vs HCC-related mortality (P = 0.3). HCC: Hepatocellular carcinoma.
- Citation: Chung W, Wong K, Ravindranayagam N, Tang L, Grace J, Wong D, Con D, Sinclair M, Majumdar A, Kutaiba N, Hui S, Gow P, Muralidharan V, Dobrovic A, Testro A. Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study. World J Transplant 2024; 14(3): 94914
- URL: https://www.wjgnet.com/2220-3230/full/v14/i3/94914.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i3.94914